[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Q32 Bio Inc (QTTB)

Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 221,954
  • Shares Outstanding, K 16,956
  • Annual Sales, $ 53,740 K
  • Annual Income, $ 29,820 K
  • EBIT $ -37 M
  • EBITDA $ -36 M
  • 60-Month Beta 0.24
  • Price/Sales 3.98
  • Price/Cash Flow 8.40
  • Price/Book 4.30

Options Overview Details

View History
  • Implied Volatility 181.53% (+4.87%)
  • Historical Volatility 211.62%
  • IV Percentile 63%
  • IV Rank 21.32%
  • IV High 491.80% on 07/08/25
  • IV Low 97.44% on 08/06/25
  • Expected Move (DTE 14) 0.00 (0.00%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 31
  • Volume Avg (30-Day) 352
  • Put/Call OI Ratio 33.67
  • Today's Open Interest 2,080
  • Open Int (30-Day) 1,039
  • Expected Range 13.09 to 13.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.57
  • Number of Estimates 2
  • High Estimate $-0.48
  • Low Estimate $-0.66
  • Prior Year $-0.78
  • Growth Rate Est. (year over year) +26.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.55 +24.08%
on 06/25/26
15.02 -12.85%
on 06/29/26
+0.45 (+3.56%)
since 06/02/26
3-Month
4.77 +174.42%
on 04/27/26
15.02 -12.85%
on 06/29/26
+6.71 (+105.17%)
since 04/02/26
52-Week
1.35 +873.23%
on 07/07/25
15.02 -12.85%
on 06/29/26
+11.65 (+809.03%)
since 07/02/25

Most Recent Stories

More News
Q32 Bio Announces $55 Million Private Placement Financing

WALTHAM, Mass. , May 27, 2026 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia...

QTTB : 13.09 (+3.89%)
Q32 Bio: Q1 Earnings Snapshot

Q32 Bio: Q1 Earnings Snapshot

QTTB : 13.09 (+3.89%)
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

-- Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 --

QTTB : 13.09 (+3.89%)
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference

WALTHAM, Mass. , April 8, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA)...

QTTB : 13.09 (+3.89%)
Q32 Bio: Q4 Earnings Snapshot

Q32 Bio: Q4 Earnings Snapshot

QTTB : 13.09 (+3.89%)
Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update

-- Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand; 36-week topline data readout expected in mid-2026 --

QTTB : 13.09 (+3.89%)
Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

WALTHAM, Mass. , Feb. 18, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA)...

QTTB : 13.09 (+3.89%)
Q32 Bio Announces $10.5 Million Registered Direct Offering

WALTHAM, Mass. , Feb. 17, 2026 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA)...

QTTB : 13.09 (+3.89%)
This Penny Biotech Stock Just Doubled on a Key Acquisition. Should You Buy Shares Here?

Q32 Bio stock soared after the biotech firm divested its ADX-097 to Akebia Therapeutics for $12 million. Here’s how you should play QTTB shares heading into 2026.

QTTB : 13.09 (+3.89%)
AKBA : 1.2400 (+2.48%)
Q32 Bio Sells Complement Inhibitor ADX-097

-- Asset sale further enables Company's strategic focus on advancing bempikibart for alopecia areata --

AKBA : 1.2400 (+2.48%)
QTTB : 13.09 (+3.89%)

Business Summary

Q32 Bio Inc. is a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis. Q32 Bio Inc., formerly known as Homology Medicines Inc., is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 14.17
2nd Resistance Point 13.74
1st Resistance Point 13.41
Last Price 13.09
1st Support Level 12.65
2nd Support Level 12.22
3rd Support Level 11.89

See More

52-Week High 15.02
Last Price 13.09
Fibonacci 61.8% 9.80
Fibonacci 50% 8.18
Fibonacci 38.2% 6.57
52-Week Low 1.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.